The objective of our study was to assess the performance of different triage strategies for
high‐risk human papillomavirus (hrHPV)‐positive results utilizing either extended …

Objectives In addition to genotyping for HPV16/18, dual-immunostaining for p16/Ki-67 has
shown promise as a triage of HPV-positive women. We assessed the performance of p16/Ki …

Background High-risk human papillomavirus (hrHPV) DNA positive women require triage
testing to identify those with high-grade cervical intraepithelial neoplasia or cancer (≥ …

Triage strategies are needed for primary human papillomavirus (HPV)‐based cervical
cancer screening to identify women requiring colposcopy/biopsy. We assessed the …

Background: Several options for the triage of high-risk HPV screen–positive (hrHPV+)
women were assessed. Methods: This study incorporated CIN2+ cases and controls, all of …

Abstract Objective To evaluate the Turkey's nationwide HPV DNA screening program on the
basis of first 4 million screened women. Methods Women over age 30 were invited for …

Simple Summary Cervical cancer is often caused by certain high-risk types of human
papillomavirus (HPV), mainly types 16 and 18. However, there are 12 other high-risk HPV …

The aim of this study was to evaluate the clinical utility of p16/Ki-67 dual staining, for the
identification of CIN in high-risk HPV-positive women from a non-responder screening …

Cytology alone, or combined with HPV16/18 genotyping, might be an acceptable method for
triage in hrHPV‐cervical cancer screening. Previously studied HPV‐genotype based triage …

Introduction: Primary HPV-testing has been shown to provide a superior detection of women
at risk of cervical (pre) cancer compared to cytology-based screening. However, as most …